ACCESS (NCT02513303): A Phase 3 US Multicenter Randomized Controlled Trial Evaluating Efficacy of a Perivascularly Delivered Sirolimus Formulation (Sirogen™) for Improving Hemodialysis AVF Outcomes

Authors

Nelson Kopyt DO, FASN, FACP, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

11-2021

Published In/Presented At

https://www.asn-online.org/abstracts/

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine

Document Type

Article